|
|
Volumn 51, Issue 2, 2008, Pages 95-99
|
|
The influence of cisplatin dose upon survival in concurrent chemoradiotherapy of locally advanced cervical carcinoma with weekly cisplatin.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
ADULT;
AGED;
ARTICLE;
BRACHYTHERAPY;
FEMALE;
HUMAN;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
SURVIVAL RATE;
UTERINE CERVIX TUMOR;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
BRACHYTHERAPY;
CISPLATIN;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
MIDDLE AGED;
SURVIVAL RATE;
UTERINE CERVICAL NEOPLASMS;
|
|
EID: 58149252444
PISSN: 12114286
EISSN: None
Source Type: Journal
DOI: 10.14712/18059694.2017.9 Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
